Category Archives: Government

All three of the world’s major drug regulators have busy week despite heat waves, political chaos. You know; the usual.

Last week was a rare case where the world’s leading drugs and devices regulators were all in action simultaneously. The US Food and Drug Administration (FDA), the European Medicines Agency… Read more »

European drug regulator comes out of hibernation in new Dutch headquarters, rivaling the FDA with rulings; well, just for one week.

It may have taken nearly 6 months and perhaps a Fourth of July holiday-shortened work week here in the US, but the European Medicines Agency (EMA) finally issued some new… Read more »

Brexit referendum slowing the European Medicines Agency’s operations to a crawl.

The News: The European Medicines Agency (EMA) recently addressed its concerns for ensuring business continuity and staff retention which had become huge challenges caused by the Brexit referendum. The EMA… Read more »

Medical Stock Spotlight: Three winners from last week hit with profit-taking, while one big loser rebounds. This week, Provention shines, but Cymabay bombs.

Stocks continue to be whipsawed by sudden upward, then plunging, prices, only to reverse direction again as political and economic uncertainty reigns supreme. Here are four prime examples of this… Read more »

The worldwide battle over health spending, especially high drug prices, and whether it’s actually worth it. The view from afar.

Commentary: Steve Walker The “Medicare for All” plan embraced by leading 2020 Democrats looks more lavish than what other advanced countries offer, compounding the cost but also potentially broadening its… Read more »

Medical stocks resemble Mr. Toad’s Wild Ride with brave investors tightening their seat belts and neck braces for more uncertainty, price fluctuation.

Health-sector stocks were whipsawed upward, downward, backward and forward last week, rekindling memories of the Yardbirds’ hit song in the 60’s with a similar name. Still, when the dust settled,… Read more »

Seven health-sector IPOs do the limbo and raise $499M, seconds before market falls off a cliff.

Trade war fears are crushing stocks, and the their swan dive onto the rocks could keep going if Presidents Trump and China’s Xi Jinping keep tossing tariff grenades at each… Read more »